Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Calliditas Therapeutics Ab ADR
(NQ:
CALT
)
40.00
UNCHANGED
Last Price
Updated: 3:53 PM EDT, Sep 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
40.00
Bid (Size)
20.29 (2)
Ask (Size)
60.85 (2)
Prev. Close
40.00
Today's Range
40.00 - 40.00
52wk Range
16.00 - 42.10
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Travere Stock Pops After Snagging Full Approval For Calliditas Rival In Kidney Disease
September 06, 2024
The company previously had an accelerated approval for its IgA nephropathy treatment.
Via
Investor's Business Daily
CALT Stock Earnings: Calliditas Therapeutics Misses EPS, Beats Revenue for Q2 2024
August 13, 2024
CALT stock results show that Calliditas Therapeutics missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Performance
YTD
+60.01%
+60.01%
1 Month
N/A
N/A
3 Month
-0.87%
-0.87%
6 Month
+75.83%
+75.83%
1 Year
+122.78%
+122.78%
More News
Read More
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BALY, MRO, SHCR, CALT on Behalf of Shareholders
July 27, 2024
From
Halper Sadeh LLC
Via
GlobeNewswire
Week In Review: MediLink And BioNTech Form $1.8 Billion ADC Partnership
June 01, 2024
Via
Talk Markets
Critical Insights From Calliditas Therapeutics Analyst Ratings: What You Need To Know
May 31, 2024
Via
Benzinga
Crude Oil Rises Sharply; Elbit Systems Shares Fall After Q1 Results
May 28, 2024
Via
Benzinga
Exposures
Fossil Fuels
Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 28, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 28, 2024
Via
Benzinga
Asahi Kasei Makes $1.1B Offer For Swedish Drugmaker Calliditas Therapeutics, Enhancing Pharma Growth Strategy
May 28, 2024
Via
Benzinga
Dow Dips Over 100 Points; GameStop Shares Spike higher
May 28, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Nvidia, Insmed, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
May 28, 2024
Via
Benzinga
CALT STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Calliditas Therapeutics AB Is Fair to Shareholders
May 28, 2024
From
Halper Sadeh LLC
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 28, 2024
Via
Benzinga
Why GameStop Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
May 28, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
May 28, 2024
Via
InvestorPlace
Apple To Rally Over 47%? Here Are 10 Top Analyst Forecasts For Friday
May 24, 2024
Via
Benzinga
CALT Stock Earnings: Calliditas Therapeutics Misses EPS, Misses Revenue for Q1 2024
May 23, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 23, 2024
Via
Benzinga
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 29, 2024
Via
Benzinga
Palo Alto Networks Issues Weak Outlook, Joins Teladoc Health, SolarEdge Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
February 21, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
What's Going On With Vera Therapeutics Stock Today?
January 26, 2024
Via
Benzinga
Exposures
Product Safety
Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
December 28, 2023
Via
Benzinga
NeoGenomics, Energy Fuels And Other Big Stocks Moving Lower On Thursday
December 28, 2023
Via
Benzinga
Topics
Intellectual Property
Lawsuit
Stocks
Exposures
Financial
Intellectual Property
Legal
Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
December 21, 2023
Via
Benzinga
Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug
December 21, 2023
Via
Benzinga
Exposures
Product Safety
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.